Committee on Biotechnology PAS ; Institute of Bioorganic Chemistry PAS
The discovery of RNA interference caused a revival of the concept of short nucleic acids application as molecular tools for therapeutic control of gene expression. After almost a decade of intensive research by leading pharmaceutical companies, there is only a limited number of clinical trials of synthetic siRNAs. In this review, we shall summarize the present status of knowledge of RNAi mechanism of action and discuss the potential of the use of siRNA in theraphy. We shall also provide data on recent achievements in current clinical trials based on RNAi techniques.
Biotechnologia, vol.84, 1 (2009)-.
0860-7796 ; oai:rcin.org.pl:73118 ; IChB B-79
Library of Institute of Bioorganic Chemistry PAS
Creative Commons Attribution BY-SA 4.0 license
Institute of Bioorganic Chemistry of the Polish Academy of Science
Institute of Bioorganic Chemistry of the Polish Academy of Science
2 paź 2020
15 cze 2019
795
https://rcin.org.pl/publication/95769
Nazwa wydania | Data |
---|---|
RNAi w terapii | 2 paź 2020 |
Borkowska, Bożenna
Ziółkowski, Piotr Babula- Skowrońska, Danuta Kaczmarek, Małgorzata Cieśla, Agata Sadowski, Jan
Sierant, Małgorzata Nawrot, Barbara